| No headlines available for JAGLX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 681.05M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 22.43% | | 5y Avg Return: | 4.53% | | Rank in Category (ytd): | 47 | | % Rank in Category (ytd): | 28.48% | | Beta (3y): | 0.74 | | Morningstar Risk Rating: | Above average |
|
| The investment seeks long-term growth of capital. The fund normally invests at least 80% of net assets in securities of companies that the portfolio manager believes have a life science orientation. It normally invests in issuers from several different countries, which may include the United States. The fund may, under unusual circumstances, invest in a single country. It normally invests at least 25% of total assets in the "life sciences" sector. The fund may have significant exposure to emerging markets. | | | Fund Profile |
|
Help
0.17 (0.80%) 
Summary
Add JAGLX to Portfolio 
Download Data
